• Latest Posts
In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

In Depth 4 Oct 2023

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

Podcast 8 Sep 2023

Beyond Biotech podcast 62 – cytokine-based drugs

Five recent advancements in ovarian cancer research over the past year

CatalYm shows importance of GDF-15 in tumor immunotherapy resistance

ADVERTISEMENT

Exeliom Biosciences closes €24M financing for lead candidate 

In Depth 27 Jun 2023

The promise of immunotherapy for autoimmune diseases

In Depth 3 May 2023

Immunotherapy in the fight against solid tumors

ADVERTISEMENT